Page last updated: 2024-10-24

regulation of defense response to virus by host

Definition

Target type: biologicalprocess

Any host process that modulates the frequency, rate, or extent of the antiviral response of a host cell or organism. [GOC:ai, GOC:dph]

The host's defense against viral infections is a complex and multifaceted process, involving a sophisticated interplay of innate and adaptive immune responses. Here's a detailed breakdown of the biological processes involved in regulating defense responses to viruses:

**1. Innate Immune Response: The First Line of Defense**

* **Pattern Recognition Receptors (PRRs):** Host cells possess PRRs that recognize pathogen-associated molecular patterns (PAMPs) specific to viruses. These PAMPs include viral nucleic acids (DNA and RNA), viral proteins, and viral envelope glycoproteins.
* **Toll-like Receptors (TLRs):** A crucial subset of PRRs, TLRs are located on the cell surface or within endosomes. They recognize specific viral components, triggering signaling pathways that activate transcription factors like NF-κB and IRF3.
* **RIG-I-like Receptors (RLRs):** These cytoplasmic sensors detect viral RNA within the cell. Upon detection, they activate downstream signaling pathways leading to the production of type I interferons (IFNs).
* **Interferon Production:** Activation of TLRs and RLRs results in the production of type I IFNs (IFN-α and IFN-β). These cytokines play a central role in antiviral defense by initiating a cascade of antiviral responses within infected and neighboring cells.

**2. Antiviral Effects of Interferons**

* **Induction of Antiviral Proteins:** IFNs activate the JAK-STAT signaling pathway, leading to the transcription of genes encoding antiviral proteins, including:
* **Mx proteins:** Inhibit viral replication by targeting viral proteins and nucleic acids.
* **PKR (protein kinase R):** Phosphorylates eIF2α, halting protein synthesis and blocking viral replication.
* **2',5'-oligoadenylate synthetase (OAS):** Produces 2',5'-oligoadenylates that activate RNase L, an enzyme that degrades viral RNA.
* **MHC Class I Up-regulation:** IFNs enhance MHC Class I expression on infected cells, promoting antigen presentation to cytotoxic T lymphocytes (CTLs).
* **Immune Cell Recruitment:** IFNs attract and activate immune cells like natural killer (NK) cells and macrophages to the site of infection.

**3. Adaptive Immune Response: Tailored Defense**

* **Antigen Presentation:** Viral antigens are presented to T cells by antigen-presenting cells (APCs) such as dendritic cells and macrophages.
* **T Cell Activation:** CD4+ helper T cells recognize viral antigens presented on MHC Class II molecules and differentiate into Th1 cells, producing cytokines like IFN-γ that further amplify the antiviral response. CD8+ cytotoxic T lymphocytes (CTLs) recognize viral antigens presented on MHC Class I molecules and directly kill infected cells.
* **Antibody Production:** B cells are activated by viral antigens and differentiate into plasma cells, producing antibodies that neutralize viral particles and facilitate their clearance.
* **Memory Immune Response:** The adaptive immune system generates memory T and B cells that can rapidly respond upon subsequent exposure to the same virus, providing long-term protection.

**4. Viral Evasion Strategies**

* **Immune Suppression:** Some viruses can evade the immune system by downregulating MHC expression, inhibiting interferon production, or producing proteins that interfere with immune cell signaling.
* **Antigenic Variation:** Viruses can rapidly mutate, changing their surface proteins to avoid recognition by antibodies and CTLs.
* **Latency:** Some viruses can establish latent infections, hiding within host cells and evading the immune system until conditions are favorable for reactivation.

**5. Regulation of the Immune Response**

* **Negative Feedback Mechanisms:** The immune response needs to be tightly regulated to prevent excessive inflammation and tissue damage. Cytokines like IL-10 and TGF-β play a role in suppressing inflammation and promoting immune homeostasis.
* **Immune Tolerance:** The immune system must distinguish between self and non-self antigens to avoid attacking healthy cells. Tolerance mechanisms are crucial in preventing autoimmunity.

**Conclusion**

The regulation of defense response to viruses by the host is a complex and dynamic process involving a coordinated interplay of innate and adaptive immune responses. This intricate interplay, characterized by the recognition of viral pathogens, the activation of antiviral pathways, the elimination of infected cells, and the development of long-term immunity, is essential for protecting the host from viral infection.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Macrophage metalloelastaseA macrophage metalloelastase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P39900]Homo sapiens (human)
Interleukin-1 betaAn interleukin-1 beta that is encoded in the genome of human. [PRO:CNA, UniProtKB:P01584]Homo sapiens (human)

Compounds (17)

CompoundDefinitionClassesRoles
5-phenylhydantoin, (+-)-isomer5-phenylhydantoin: structure given in first source
clodronic acidclodronic acid : An organochlorine compound that is methylene chloride in which both hydrogens are replaced by phosphonic acid groups. It inhibits bone resorption and soft tissue calcification, and is used (often as the disodium salt tetrahydrate) as an adjunct in the treatment of severe hypercalcaemia associated with malignancy, and in the management of osteolytic lesions and bone pain associated with skeletal metastases.

Clodronic Acid: A diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification.
1,1-bis(phosphonic acid);
one-carbon compound;
organochlorine compound
antineoplastic agent;
bone density conservation agent
marimastatmarimastat : A secondary carboxamide resulting from the foraml condensation of the carboxy group of (2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the alpha-amino group of N,3-dimethyl-L-valinamide.

marimastat: a matrix metalloproteinase inhibitor active in patients with advanced carcinoma of the pancreas, prostate, or ovary
hydroxamic acid;
secondary carboxamide
antineoplastic agent;
matrix metalloproteinase inhibitor
ilomastatCS 610: matrix metalloproteinase inhibitor; structure in first source

ilomastat : An N-acyl-amino acid obtained by formal condensation of the carboxy group of (2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the amino group of N-methyl-L-tryptophanamide. A cell permeable broad-spectrum matrix metalloproteinase (MMP) inhibitor
hydroxamic acid;
L-tryptophan derivative;
N-acyl-amino acid
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
EC 3.4.24.24 (gelatinase A) inhibitor;
neuroprotective agent
taxifolin(+)-taxifolin : A taxifolin that has (2R,3R)-configuration.taxifolinmetabolite
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
luteolin3'-hydroxyflavonoid;
tetrahydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
n-acetyltyrosyl-valyl-alanyl-aspartyl aldehyde
isoacteosideisoacteoside: a phenylethanoid glycoside isolated from Indian paintbrush (Verbenaceae) Castilleja linariaefolia; also in other plants; structure given in first sourcehydroxycinnamic acid
Methyl rosmarinatehydroxycinnamic acid
(11c)cgs 25966
ageladine aageladine A : An imidazopyridine that is 1H-imidazo[4,5-c]pyridin-2-amine substituted by a 4,5-dibromo-1H-pyrrol-2-yl group at position 4. It is an alkaloid isolated from a marine sponge Agelas nakamurai and acts as an inhibitor of the matrix metalloproteinases, the key enzymes involved in tumour growth, migration, angiogenesis, invasion and metastasis.

Ageladine A: an antiangiogenic matrixmetalloproteinase inhibitor from the marine sponge Agelas nakamurai; structure in first source
alkaloid;
aromatic amine;
imidazopyridine;
organobromine compound;
pyrroles
angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor;
metabolite
N(2)-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N(2)-isopropoxy-D-valinamideN(2)-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N(2)-isopropoxy-D-valinamide : A hydroxamic acid that is N-hydroxy-D-valinamide in which the alpha-amino group has been substituted by isopropoxy and [biphenyl]-4-ylsulfonyl groups. A selective matrix metalloproteinase-2 (MMP-2) inhibitor, it is one of the most potent inducers of autophagy. Its physiological roles include angiogenesis, cancer metastasis, embryogenesis, tissue remodeling in development, and wound healing.D-valine derivative;
hydroxamic acid
antineoplastic agent;
autophagy inducer;
EC 3.4.24.24 (gelatinase A) inhibitor;
melanin synthesis inhibitor
bms-566394BMS-566394: structure in first source
incb3619INCB3619: ADAM inhibitor; structure in first source
berkeleydioneberkeleydione : A meroterpenoid found in Penicillium rubrum. It has been shown to exhibit inhibitory activity against caspase-1.

berkeleydione: polyketide-terpenoid metabolite, isolated from a Penicillium sp.; structure in first source
beta-diketone;
cyclic terpene ketone;
meroterpenoid;
methyl ester;
organic heterotetracyclic compound;
terpene lactone;
tertiary alcohol;
tertiary alpha-hydroxy ketone
antineoplastic agent;
cysteine protease inhibitor;
Penicillium metabolite
grassystatin agrassystatin A: isolated from a cyanobacterium, identified as Lyngbya cf.; structure in first source